High calpain-2 expression in breast cancer is associated with poor survival in patients with triple negative or basal-like phenotype tumours; and high expression of calpain-1 can predict response following adjuvant trastuzumab therapy [2, 3]. The gene discussed is CAPN2; the disease is breast cancer.